<i>Hepatology</i>｜Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway

doi:10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2

Volume 38 Issue 2

Feb. 2022

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(2): 319-319

PDF( 1389 KB)

Hepatology｜Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway

DOI: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2

Published Date: 2022-02-20

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	Journal of Gastroenterology and Hepatology｜Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway[J]. Journal of Clinical Hepatology, 2024, 40(5): 1049-1049. doi: 10.12449/JCH2405.gwqkjpwzjj4
[2]	Journal of Gastroenterology and Hepatology｜Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis[J]. Journal of Clinical Hepatology, 2023, 39(11): 2523-2523. doi: 10.3969/j.issn.1001-5256.2023.11.gwjpwzjj1
[3]	Hepatology Research｜Clinical features of chronic hepatitis B patients with lean nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2023, 39(5): 1171-1171. doi: 10.3969/j.issn.1001-5256.2023.05.gwjpwzjj3
[4]	Guangyue YANG, Le TAO, Wei ZHANG, Xuling LIU, Wenting MA, Liu WU, Tiantian SUN, Hao JIANG, Cheng LIU. Mechanism of action of Eupolyphaga steleophaga in improving nonalcoholic steatohepatitis by regulating syndecan 3[J]. Journal of Clinical Hepatology, 2022, 38(7): 1513-1520. doi: 10.3969/j.issn.1001-5256.2022.07.012
[5]	Shudi LI, Xinju CHEN, Jiangkai LIU, Zhen WANG, Fei DUAN, Zhuoya YUAN, Lei LIANG, Suling LI. Signaling pathways involved in the active components of Polygonum cuspidatum in treatment of nonalcoholic fatty liver disease and their interaction[J]. Journal of Clinical Hepatology, 2022, 38(4): 902-907. doi: 10.3969/j.issn.1001-5256.2022.04.033
[6]	Hepatology｜Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(9): 2039-2039. doi: 10.3969/j.issn.1001-5256.2022.09.gwjpwzjj3
[7]	Hepatology｜ Peroxisome proliferator - activated receptor α promotes liver enlargement and liver regeneration via the YAP-TEAD signaling pathway[J]. Journal of Clinical Hepatology, 2022, 38(2): 341-341. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj3
[8]	Hepatology｜Myeloid cell-specific IL-6 signal alleviates nonalcoholic fatty liver disease-related fibrosis by promoting the release of microRNA-223-enriched exosome[J]. Journal of Clinical Hepatology, 2022, 38(2): 414-414. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj6
[9]	Gege TIAN, Enrui XIA, Suyan ZHANG, Shunzhen ZHAGN, Furong XU. Research advances in traditional Chinese medicine in improving nonalcoholic steatohepatitis by regulating the Toll-like receptor 4/nuclear factor-kappa B signaling pathway[J]. Journal of Clinical Hepatology, 2021, 37(12): 2957-2962. doi: 10.3969/j.issn.1001-5256.2021.12.047
[11]	Xiang Zhao, Yang JinHui. Role of the OPG/RANKL/RANK signaling pathway in the progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(7): 1631-1633. doi: 10.3969/j.issn.1001-5256.2020.07.040
[13]	Sun TingTing, Li JingTao, Wei HaiLiang, Yan ShuGuang, Li Qian, Guo YingJun, Chang ZhanJie. Research advances in the role of the TNF-α/NF-κB signaling pathway in the regulation of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(9): 2095-2098. doi: 10.3969/j.issn.1001-5256.2019.09.047
[14]	Yan Hua, Zhang Ying, Wang Huan, Gao YanQiong, Liu GuiSheng, Lei JianYuan. Chlorogenic acid exerts preventive and therapeutic effects on nonalcoholic fatty liver disease by inhibiting the JNK signaling pathway[J]. Journal of Clinical Hepatology, 2018, 34(2): 359-363. doi: 10.3969/j.issn.1001-5256.2018.02.028
[15]	Zhao WenXia, Yan Le, Shao MingYi, Zhang LiHui. Effect of Huatan Qushi Huoxue prescription on the ADPN/AMPK/ACC signaling pathway in rats with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2017, 33(5): 932-936. doi: 10.3969/j.issn.1001-5256.2017.05.029
[18]	An BaiQuan, Jiang Man, Xin YongNing, Jiang XiangJun, Liu ZhenSheng, Xuan ShiYing. Role of Hedgehog signaling pathway in progression of non-alcoholic fatty liver fibrosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 457-459. doi: 10.3969/j.issn.1001-5256.2015.03.035
[19]	Song HaiYan, Mao ZhiMin, Yang LiLi, Zhang Li, Ge YingLi, Liu Tao, Liu Ping, Ji Guang. Mechanism of Dangfei Liganning Capsule attenuating nonalcoholic steatotic hepatitis induced by high-fat diet combined with carbon tetrachloride in rats[J]. Journal of Clinical Hepatology, 2012, 28(3): 196-200.
[20]	Cai WeiMin. Endocannabinoid receptors and nonalcoholic steatohepatitis [J]. Journal of Clinical Hepatology, 2010, 26(2): 149-152.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (287) PDF downloads(26)

Hepatology｜Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway

DOI: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Hepatology｜Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway

DOI: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content